Abivax releases the results of its May 30, 2024 Ordinary and Extraordinary General Meeting
ABIVAX Société Anonyme (NASDAQ: ABVX) is now covered by analysts at BTIG Research. They set a "buy" rating and a $43.00 price target on the stock.
ABIVAX Société Anonyme (NASDAQ: ABVX) is now covered by analysts at Guggenheim. They set a "buy" rating and a $50.00 price target on the stock.
ABIVAX Société Anonyme (NASDAQ: ABVX) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $42.00 price target on the stock.
ABIVAX Société Anonyme (NASDAQ: ABVX) had its price target raised by analysts at Morgan Stanley from $15.00 to $16.00. They now have an "equal weight" rating on the stock.